Validation study for the WID-qEC test in women undergoing hysterectomy: A diagnostic accuracy study

ISRCTN ISRCTN12164818
DOI https://doi.org/10.1186/ISRCTN12164818
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number Nil known
Sponsor University Hospital of Bern
Funders labor team w ag, Women's Clinic Inselspital Bern
Submission date
29/01/2025
Registration date
10/02/2025
Last edited
10/03/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The POPCORN study will analyze the performance of the WID-qEC diagnostic test for endometrial carcinoma.

Who can participate?
All women undergoing hysterectomy at the University Hospital in Bern, Switzerland

What does the study involve?
The participants will be asked to undergo a WID-qEC test before their operation during their visit where a vaginal examination is planned. After that, the planned hysterectomy will be performed, no matter the underlying disease. The WID-qEC test results will then be compared to the histology results of the hysterectomy to evaluate the accuracy of the test and try to identify confounding factors.

What are the possible benefits and risks of participating?
There are no foreseen possible benefits from participation. The risks are slight bleeding at the site of sampling in the vagina, although this is very rare.

Where is the study run from?
Inselspital Bern, Switzerland

When is the study starting and how long is it expected to run for?
January 2025 to January 2026

Who is funding the study?
The labor team w in St. Gallen, Switzerland, provides the tests without cost to patients

Who is the main contact?
Franziska Siegenthaler MD, franziska.siegenthaler@insel.ch

Contact information

Dr Franziska Siegenthaler
Public, Scientific, Principal investigator

Inselspital - University Hospital of Bern
Friedbühlstrasse 19
Bern
3011
Switzerland

Phone +41 632 10 10
Email franziska.siegenthaler@insel.ch

Study information

Primary study designObservational
Study designNon-randomized diagnostic accuracy study
Secondary study designProspective diagnostic accuracy study
Study type Participant information sheet
Scientific titlePrOsPective observational COhoRt study on the performaNce of the WID-qEC test in patients undergoing hysterectomy
Study acronymPopcorn
Study objectivesThis study evaluates the sensitivity and specificity of the WID-qEC test to evaluate its performance and identify factors that influence its performance.
Ethics approval(s)

Approved 29/01/2025, Cantonal Ethics Committee for Research Bern (Rathausgasse 1, Bern, 3011, Switzerland; +41 31 633 70 70; mario.amacker@be.ch), ref: 2024-02365

Health condition(s) or problem(s) studiedPerformance of the WID-qEC test to accurately detect endometrium carcinoma in women who undergo planned hysterectomy
InterventionThe WID-qEC test is used before the hysterectomy in a non-randomised allocation. The results of the WID-qEC test will be compared with the final histology to evaluate sensitivity and specificity.

Patients are sampled consecutively when they have a planned total hysterectomy at University Hospital in Bern. There has been no Standard Test up till now, the nearest to fulfill this description is a transvaginal ultrasound. Therefore, the index Test (WID-qEC Test) is not compared to standard testing. The performance of the transvaginal ultrasound and the WID-qEC Test is mainly used when the symptom of postmenopausal bleeding occurs. However, the transvaginal ultrasound will not be replaced by the WID-qEC test. It is thought to be an additional diagnostic tool to prevent further interventional diagnostics such as a hysteroscopy which is mostly unnecessary (in case of non-malignant bleeding). There is no follow-up after the test has been taken.
Intervention typeDevice
PhaseNot Applicable
Drug / device / biological / vaccine name(s)WID-qEC test
Primary outcome measure(s)

The sensitivity and specificity of the WID-qEC test result measured using samples obtained from the cervicovaginal region immediately before the hysterectomy for the detection of endometrial/cervical cancers compared to a histology hysterectomy specimen

Key secondary outcome measure(s)

1. The underlying pathology of the ectocervix, cervical canal, endometrium and fallopian tube (and if also removed the ovary) in patients whose WID-qEC test (measured using histopathology of samples obtained from the cervicovaginal region immediately before the hysterectomy) is a false positive (i.e. WID-qEC test is positive in the absence of cancer in the hysterectomy/adnexal specimen).
2. The underlying pathology of the ectocervix, cervical canal and endometrium in patients whose WID-qEC test (measured using histopathology of samples obtained from the cervicovaginal region immediately before the hysterectomy) is a false negative (i.e. WID-qEC test is negative despite the presence of an invasive cancer in the cervix or the endometrial cavity).
3. To compare the level of the sum of the percentage of fully methylated reference (PMR) values of the WID-qEC test (using samples obtained from the cervicovaginal region immediately before the hysterectomy) with the immunohistochemical markers assessed in the cancerous endometrium (p53, MMR markers, Ki67) or non-cancer patients (Ki67 only) in the normal endometrium or the most advanced hyperplastic lesion.

Completion date31/01/2026

Eligibility

Participant type(s)Population
Age groupMixed
Lower age limit18 Years
SexFemale
Target sample size at registration350
Key inclusion criteriaUndergoing total hysterectomy at University Hospital Bern, CH
Key exclusion criteria1. Lack of capacity to provide written informed consent
2. Refusal to participate in the study
3. Presence of medical conditions contraindicating general anesthesia
Date of first enrolment03/03/2025
Date of final enrolment31/01/2026

Locations

Countries of recruitment

  • Switzerland

Study participating centre

Inselspital Bern, University Hospital Bern
Friedbühlstrasse 19
Bern
3011
Switzerland

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

10/03/2025: The recruitment start date was changed from 17/02/2025 to 03/03/2025.
12/02/2025: The recruitment start date was changed from 01/02/2025 to 17/02/2025.
31/01/2025: Study's existence confirmed by the Cantonal Ethics Committee for Research Bern.